Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. 1998

F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
Transplantation Biology Research Center, Massachusetts General Hospital, Boston 12129, USA.

BACKGROUND Intravascular fibrin deposition and platelet sequestration occur with porcine xenograft rejection by baboons. Disseminated intravascular coagulopathy may arise either as a direct consequence of the failure to fully deplete xenoreactive natural antibodies and block complement, or because of putative cross-species molecular incompatibilities in this discordant species combination. METHODS Three baboons were conditioned with retrovirally transduced autologous bone marrow to induce tolerance to swine antigens. Xenoreactive natural antibodies and complement were depleted by plasmapheresis and the use of Gal alpha1-3Gal column adsorptions; baboons were then splenectomized and underwent renal xenografting from inbred, miniature pigs. Soluble complement receptor type-1 with protocol immunosuppression (mycophenolate mofetil, 15-deoxyspergualin, steroids, and cyclosporine) was administered. RESULTS A bleeding diathesis was clinically evident from days 5 to 12 after transplantation in two baboons. Low levels of circulating C3a, C3d, and iC3b were measured despite the absence of functional circulating complement components. Profound thrombocytopenia with abnormalities in keeping with disseminated intravascular coagulopathy were observed. Prolongation of prothrombin and partial thromboplastin times was accompanied by evidence for tissue factor-mediated coagulation pathways, high levels of thrombin generation (prothrombin fragment F(1+2) production and thrombin-antithrombin complex formation), fibrinogen depletion, and production of high levels of the fibrin degradation product D-dimer. Importantly, these disturbances resolved rapidly after the excision of the rejected xenografts in two surviving animals. Histopathological examination of the rejected xenografts confirmed vascular injury, fibrin deposition, platelet deposition, and localized complement activation. CONCLUSIONS Systemic coagulation disturbances are associated with delayed xenograft rejection.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D010215 Papio A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio. Baboons,Baboons, Savanna,Savanna Baboons,Baboon,Baboon, Savanna,Papios,Savanna Baboon
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
January 2001, Transplantation proceedings,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
June 2002, Transplantation,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
January 2001, Transplantation proceedings,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
June 1999, The Journal of thoracic and cardiovascular surgery,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
April 1996, Transplantation proceedings,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
January 1995, Transplantation,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
August 1970, The New England journal of medicine,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
September 1991, Critical care medicine,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
December 1974, The Journal of the Association of Physicians of India,
F L Ierino, and T Kozlowski, and J B Siegel, and A Shimizu, and R B Colvin, and P T Banerjee, and D K Cooper, and A B Cosimi, and F H Bach, and D H Sachs, and S C Robson
June 1968, Lancet (London, England),
Copied contents to your clipboard!